|
US1975A
(en)
|
|
1841-02-12 |
|
Manner of constructing corn-shellers |
|
DE3572982D1
(en)
|
1984-03-06 |
1989-10-19 |
Takeda Chemical Industries Ltd |
Chemically modified lymphokine and production thereof
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
JPS6412935A
(en)
|
1987-07-02 |
1989-01-17 |
Mitsubishi Electric Corp |
Constant-speed travel device for vehicle
|
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
|
WO1990006952A1
(fr)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Facteur de stimulation de colonies de granulocytes modifies chimiquement
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
CA2118508A1
(en)
|
1992-04-24 |
1993-11-11 |
Elizabeth S. Ward |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
EP0983303B1
(en)
|
1997-05-21 |
2006-03-08 |
Biovation Limited |
Method for the production of non-immunogenic proteins
|
|
PL209392B1
(pl)
|
1999-01-15 |
2011-08-31 |
Genentech Inc |
Przeciwciało, komórka gospodarza, sposób wytwarzania przeciwciała oraz zastosowanie przeciwciała
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
US20030059427A1
(en)
|
2000-04-28 |
2003-03-27 |
Force Walker R. |
Isolation and characterization of highly active anti-CD40 antibody
|
|
CA2658221C
(en)
|
2001-04-27 |
2012-11-27 |
Kyowa Kirin Co., Ltd. |
Anti-cd40 monoclonal antibody
|
|
WO2004041863A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Single domain antibodies directed against interferon- gamma and uses therefor
|
|
US20100003253A1
(en)
*
|
2002-11-08 |
2010-01-07 |
Ablynx N.V. |
Single domain antibodies directed against epidermal growth factor receptor and uses therefor
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
EP2314620B1
(en)
|
2004-05-27 |
2013-06-05 |
Crucell Holland B.V. |
Method of identifying binding molecules capable of neutralizing rabies virus
|
|
JP4829609B2
(ja)
|
2004-12-22 |
2011-12-07 |
独立行政法人科学技術振興機構 |
ヒト抗体酵素およびその生産方法
|
|
EP1937814A4
(en)
*
|
2005-09-01 |
2010-05-05 |
Ca Nat Research Council |
ANTIAPOPTOTIC PROTEIN ANTIBODY
|
|
EP2064350B1
(en)
|
2006-11-27 |
2013-01-02 |
Ludwig Institute for Cancer Research Ltd. |
Expression of foxp3 by cancer cells
|
|
TWI441648B
(zh)
|
2007-01-03 |
2014-06-21 |
Oncotherapy Science Inc |
Ｆｏｘｐ３胜肽疫苗
|
|
WO2009003489A1
(en)
*
|
2007-07-02 |
2009-01-08 |
Natimmune A/S |
CaOU-1 EPITOPE BINDING POLYPEPTIDES
|
|
EP2020419A1
(en)
*
|
2007-07-31 |
2009-02-04 |
Bayer Schering Pharma Aktiengesellschaft |
Anti ephB4 antibody fragments
|
|
RU2010127156A
(ru)
|
2007-12-06 |
2012-01-20 |
Дана-Фарбер Кэнсер Инститьют, Инк. (Us) |
Антитела против вируса гриппа и их применение
|
|
US8540987B2
(en)
*
|
2008-01-29 |
2013-09-24 |
Institute For Antibodies Co., Ltd. |
Composition for neutralizing botulinus toxin type-A, and human anti-botulinus toxin type-A antibody
|
|
WO2009134339A2
(en)
*
|
2008-04-29 |
2009-11-05 |
Monsanto Technology, Llc |
Genes and uses for plant enhancement
|
|
WO2010039750A2
(en)
*
|
2008-10-01 |
2010-04-08 |
Monsanto Technology Llc |
Transgenic plants with enhanced agronomic traits
|
|
CA2742969A1
(en)
|
2008-11-07 |
2010-05-14 |
Fabrus Llc |
Anti-dll4 antibodies and uses thereof
|
|
WO2010099083A1
(en)
*
|
2009-02-27 |
2010-09-02 |
Monsanto Technology Llc |
Isolated novel nucleic acid and protein molecules from soybeans and methods of using those molecules
|
|
SG182408A1
(en)
|
2010-01-11 |
2012-08-30 |
Alexion Pharma Inc |
Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2012104344A1
(en)
*
|
2011-02-01 |
2012-08-09 |
Genmab A/S |
Human antibodies and antibody-drug conjugates against cd74
|
|
US20130102031A1
(en)
|
2011-10-25 |
2013-04-25 |
Anaptysbio, Inc. |
Use of somatic hypermutation to create insertion and deletion mutations in vitro
|
|
KR20220084444A
(ko)
|
2012-05-31 |
2022-06-21 |
소렌토 쎄라퓨틱스, 인코포레이티드 |
Pd-l1에 결합하는 항원 결합 단백질
|
|
US9561266B2
(en)
*
|
2012-08-31 |
2017-02-07 |
University Of Virginia Patent Foundation |
Target peptides for immunotherapy and diagnostics
|
|
EP3066130B1
(en)
|
2013-11-07 |
2019-05-15 |
Memorial Sloan-Kettering Cancer Center |
Anti-wt1/hla bi-specific antibody
|
|
WO2015097536A2
(en)
|
2013-12-24 |
2015-07-02 |
Janssen Pharmaceutical Nv |
Anti-vista antibodies and fragments
|
|
GB201410520D0
(en)
*
|
2014-06-12 |
2014-07-30 |
Univ London Queen Mary |
Antibody
|